BAKER BROS. ADVISORS LP – Travere Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$81.31M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+1.69%
quarter
Travere Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.35M | $24.64 | 3.30M | |
| Q2 2022 | share | 0.00% | 0 shares | -5.08M | $24.23 | 3.30M | |
| Q1 2022 | share | Increase | +23.64% | 630.95K shares | 2.19M | $25.77 | 3.30M |
| Q4 2021 | share | Increase | +30.85% | 629.28K shares | 33.38M | $30.31 | 2.66M |
| Q3 2021 | share | Increase | +991.28% | 1.85M shares | 46.73M | $24.25 | 2.03M |
| Q2 2021 | share | 0.00% | 0 shares | -1.94M | $14.59 | 186.91K | |
| Q1 2021 | share | Increase | 0.00% | 186.91K shares | 4.66M | $24.97 | 186.91K |